INS and diabetes mellitus: More than a century after the introduction of treatment with insulin, T1D still represents a disease with considerable therapeutic need, not only because of the burden of constant administration of exogenous insulin, but also because chronic and degenerative complications still occur in a sizable fraction of T1D patients despite considerable improvements in diabetes management and care (103–105).